School News

Sprowl receives ASPET Division for Translational and Clinical Pharmacology Early Career Award
2/1/23
Jason Sprowl, PhD, assistant professor of pharmaceutical sciences, has received a 2023 Division for Translational and Clinical Pharmacology Early Career Award from The American Society for Pharmacology and Experimental Therapeutics (ASPET).
UB receives $2.1 million grant to prevent toxic side effects of leukemia treatment
1/29/23
The project aims to develop drugs that target cancer cells as well as drugs that may help prevent anti-cancer molecules from harming healthy cells.
Balthasar lab receives $2.1 million grant to prevent toxic side effects of leukemia treatment
1/29/23
The project aims to develop drugs that target cancer cells as well as drugs that may help prevent anti-cancer molecules from harming healthy cells.
Qu research team develops a groundbreaking proteomic technique, Micro-scaffold Assisted Spatial Proteomic (MASP), allowing first ever simultaneous whole-tissue protein mapping with excellent accuracy
1/17/23
University at Buffalo School of Pharmacy and Pharmaceutical Sciences (UB SPPS) research teams led by Jun Qu, PhD, professor, Department of Pharmaceutical Sciences, were recently recognized by Nature Communications, an open access journal affiliated with Nature, the premier international science and technology journal, for their groundbreaking techniques for in-depth mapping of protein localizations in whole tissue.
Qu research team’s novel work with Ionstar, an integrated quantitative proteomics pipeline for high-quality and robust protein quantification in large clinical/pharmaceutical cohorts, was published and recognized by Nature Protocols
1/17/23
University at Buffalo School of Pharmacy and Pharmaceutical Sciences (UB SPPS) research teams led by Jun Qu, PhD, professor, Department of Pharmaceutical Sciences, published the protocol of their IonStar techniques and was recognized by Nature Protocols, an open access journal affiliated with Nature, the premier international science and technology journal, for their high impact work in proteomics investigation.
Origins of new autoimmune drugs found in Balthasar lab
12/14/22
A groundbreaking discovery by Joseph Balthasar’s research team has led to new treatments for autoimmunity.
Clinician scientist Waheed Adedeji receives NIH award to study interaction of mental health and HIV medication in Nigeria
12/2/22
Adedeji, also a scholar at the UB Center for Integrated Global Biomedical Sciences (CIGBS), will receive mentorship and training through CIGBS.
Waheed Adedeji, UB Center for Integrated Global Biomedical Sciences scholar, receives NIH award to study interaction of mental health and HIV medication in Nigeria
12/2/22
Adedeji, a clinician and scientist at the University of Ibadan in Nigeria and a scholar at the UB Center for Integrated Global Biomedical Sciences (CIGBS), will receive mentorship and training through CIGBS.
New tool twice as accurate at predicting antibody resistance among U.S. children with Kawasaki disease
12/2/22
UB-developed scoring system lays groundwork for North America’s first test to predict therapeutic resistance for the rare, but severe disease.